CRXX Insider Trading Activity and SEC Form 4 Filings
CRXX insider trading summary
No open-market insider purchases or sales of Combinatorx, Inc (CRXX) have been reported on SEC Form 4 in the past 12 months.
Latest CRXX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Apr 22, 2010 | Hartley T Richardson | Director | Buy | $466 (343 @ $1.36) |
| Apr 13, 2010 | Hartley T Richardson | Director | Buy | $200K (161,200 @ $1.24) |
| Jan 26, 2010 | Jason Cole | Senior VP & General Counsel | Sell | $2K (2,542 @ $0.93) |
| Dec 22, 2009 | Biotechnology Value Fund L P | Insider | Sell | $430K (538,000 @ $0.80) |
| Dec 22, 2009 | Bvf Investments LLC | Insider | Sell | $430K (538,000 @ $0.80) |
| Dec 22, 2009 | Bvf Partners L P/Il | 10% Owner | Sell | $430K (538,000 @ $0.80) |
| Dec 22, 2009 | Bvf Inc/Il | 10% Owner | Sell | $622K (776,899 @ $0.80) |
| Dec 22, 2009 | Biotechnology Value Fund II LP | Insider | Sell | $430K (538,000 @ $0.80) |
| Dec 22, 2009 | Biotechnology Value Fund II LP | Insider | Sell | $622K (776,899 @ $0.80) |
| Dec 22, 2009 | Bvf Investments LLC | Insider | Sell | $1.5M (1,863,000 @ $0.80) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.